Controlled release drug delivery involves releasing a drug at predetermined rates and targeted areas of the body for achieving better clinical results. It helps reduce fluctuation of drug levels in blood and maintains drug concentration within therapeutic limits to improve treatment efficiency and safety. The major controlled release technologies include transdermal, oral, implantable and injectable systems. The global controlled release drug delivery market is driven by growing prevalence of chronic diseases, increased demand for convenient drug administration and better treatment outcomes.
Global controlled release drug delivery market is estimated to be valued at USD 52.5 Bn in 2024 and is expected to reach USD 106.1 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 10.6% from 2024 to 2031.
Key Takeaways
Key players operating in the controlled release drug delivery are Orbis Biosciences, Inc., Merck and Co., Inc., Alkermes plc, Johnson and Johnson, Coating Place, Inc., Corium International, Inc., Depomed, Inc., Pfizer, Inc, Aradigm Corporation, Capsugel. Growing geriatric population suffering from multiple chronic conditions like diabetes, arthritis, cancer is accelerating the demand for controlled release drug formulations for better management of diseases. Technological developments in polymer science, nanotechnology and 3D printing have enabled design of innovative drug delivery systems with controllable drug release properties.
Market Trends
Controlled Release Drug Delivery Market Demand are gaining popularity owing to benefits like risk reduction of dose dumping, ability to provide site-specific delivery and possibility of incorporating various APIs. Miniaturization of drug delivery devices using micro-nano technologies help enhance portability, convenience of use and achieve flexible dosing.
Market Opportunities
Increasing demand for self-administered and home healthcare products present opportunities for development of user-friendly controlled release drug delivery patches, sprays and ingestible devices. 3D printing allows customized design of implants with complex geometries and multiple API release profiles to meet personalized therapeutic needs.
Impact of COVID-19 on Controlled Release Drug Delivery Market Growth
The COVID-19 pandemic has significantly impacted the growth of the controlled release drug delivery market. During the initial outbreak period, there was lower demand from non-critical therapeutic areas due to lockdowns and treatment delays. However, with time, the demand increased for controlled delivery of drugs used in treating COVID-19 symptoms. Manufacturers have focused on controlled delivery formulations of antiviral drugs, steroids and supportive care medications.
Get more insights on Controlled Release Drug Delivery Market
For More Insights Discover the Report In language that Resonates with you:-
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian